Given the amount of recent legislative and regulatory activity regarding a variety of issues relative to drug pricing, the Roundtable presented a webinar for members and friends on Tuesday, August 6th.
The upcoming Congressional summer recess provides an opportunity for us to step back and review recent legislative and regulatory activity regarding critical Roundtable priorities. The webinar included a discussion of the bipartisan drug pricing bill advanced by the Senate Finance Committee and other pending House and Senate proposals. In addition, presenters discussed what we expect to see when Congress reconvenes in September.
Click here to obtain a copy of the Webinar Presentation.